EYES logo

EYES Cash From Investing

Annual CFI

-$14.00 K
-$82.00 K-120.59%

December 31, 2021

Summary

Performance

1-Year Change

-120.59%

3-Year Change

+91.41%

5-Year Change

+94.72%

15-Year Change

+94.72%

EYES Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$17.52 M
EYES annual cash flow from investing activities is currently -100.08% below its historical high of $17.52 million

3-Year Low

-$14.00 K
EYES annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
EYES previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
EYES next annual earnings announcement has not yet been scheduled

OtherEYEScash flowmetrics:

Annual CFF

$75.62 M
EYES annual cash flow from financing activities is $75.62 million

Annual CFO

-$9.19 M
EYES annual cash flow from operations is -$9.19 million

Annual FCF

-$9.20 M
EYES annual free cash flow is -$9.20 million

Annual CAPEX

-
EYES annual capital expenditures value is unknown

Quarterly CFI

$0.00
+$8.02 M+100.00%

June 30, 2022

Summary

Performance

3-Month Change

+100%

1-Year Change

0%

3-Year Change

+100%

5-Year Change

+100%

EYES Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$6.04 M
EYES quarterly cash flow from investing activities is currently -100.00% below its historical high of $6.04 million

3-Year Low

-$8.02 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
EYES previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
EYES next earnings announcement has not yet been scheduled

OtherEYEScash flowmetrics:

Quarterly CFF

$0.00
EYES quarterly cash flow from financing activities is $0.00

Quarterly CFO

-$3.22 M
EYES quarterly cash flow from operations is -$3.22 million

Quarterly FCF

-$3.22 M
EYES quarterly free cash flow is -$3.22 million

Quarterly CAPEX

-
EYES quarterly capital expenditures value is unknown

TTM CFI

-$8.03 M
$0.000.00%

June 30, 2022

Summary

Performance

3-Month Change

0%

1-Year Change

-2113.03%

3-Year Change

-1529.21%

5-Year Change

-1529.21%

EYES TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$18.53 M
EYES TTM cash flow from investing activities is currently -143.35% below its historical high of $18.53 million

3-Year Low

-$8.03 M
EYES TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
EYES previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
EYES next earnings announcement has not yet been scheduled

OtherEYEScash flowmetrics:

TTM CFF

$2000.00
EYES TTM cash flow from financing activities is $2000.00

TTM CFO

-$9.42 M
EYES TTM cash flow from operations is -$9.42 million

TTM FCF

-$9.44 M
EYES TTM free cash flow is -$9.44 million

TTM CAPEX

-
EYES TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

EYES Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-120.6%0.0%-2113.0%
3 y3 years+91.4%+100.0%-1529.2%
5 y5 years+94.7%+100.0%-1529.2%

EYES Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high<-9999.0%>+9999.0%at low
5 y5-year-120.6%+3421.4%-100.0%<-9999.0%-2113.0%at low
alltimeall time-100.1%>+9999.0%-100.0%<-9999.0%-143.4%+223.1%

Second Sight Medical Products Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2022
-
$0.00(-100.0%)
-$8.03 M(0.0%)
Mar 2022
-
-$8.02 M(>+9900.0%)
-$8.03 M(>+9900.0%)
Dec 2021
-$14.00 K(-120.6%)
-$14.00 K(<-9900.0%)
-$14.00 K(-1500.0%)
Sep 2021
-
$0.00(0.0%)
$1000.00(-99.7%)
Jun 2021
-
$0.00(0.0%)
$399.00 K(0.0%)
Mar 2021
-
$0.00(-100.0%)
$399.00 K(+486.8%)
Dec 2020
$68.00 K(-113.8%)
$1000.00(-99.7%)
$68.00 K(-312.5%)
Sep 2020
-
$398.00 K(>+9900.0%)
-$32.00 K(-95.2%)
Jun 2020
-
$0.00(-100.0%)
-$660.00 K(-16.1%)
Mar 2020
-
-$331.00 K(+234.3%)
-$787.00 K(+59.6%)
Dec 2019
-$493.00 K(+202.5%)
-$99.00 K(-57.0%)
-$493.00 K(+19.4%)
Sep 2019
-
-$230.00 K(+81.1%)
-$413.00 K(+95.7%)
Jun 2019
-
-$127.00 K(+243.2%)
-$211.00 K(+59.8%)
Mar 2019
-
-$37.00 K(+94.7%)
-$132.00 K(-19.0%)
Dec 2018
-$163.00 K(-38.5%)
-$19.00 K(-32.1%)
-$163.00 K(-28.5%)
Sep 2018
-
-$28.00 K(-41.7%)
-$228.00 K(-0.9%)
Jun 2018
-
-$48.00 K(-29.4%)
-$230.00 K(-5.7%)
Mar 2018
-
-$68.00 K(-19.0%)
-$244.00 K(-7.9%)
Dec 2017
-$265.00 K
-$84.00 K(+180.0%)
-$265.00 K(-117.0%)
DateAnnualQuarterlyTTM
Sep 2017
-
-$30.00 K(-51.6%)
$1.55 M(-79.6%)
Jun 2017
-
-$62.00 K(-30.3%)
$7.62 M(-218.6%)
Mar 2017
-
-$89.00 K(-105.1%)
-$6.42 M(+1211.0%)
Dec 2016
-$490.00 K(-102.8%)
$1.74 M(-71.2%)
-$490.00 K(-115.0%)
Sep 2016
-
$6.04 M(-142.8%)
$3.27 M(+89.5%)
Jun 2016
-
-$14.11 M(-341.4%)
$1.73 M(-90.7%)
Mar 2016
-
$5.84 M(+6.4%)
$18.53 M(+5.8%)
Dec 2015
$17.52 M(-167.5%)
$5.50 M(+22.3%)
$17.52 M(-181.9%)
Sep 2015
-
$4.49 M(+66.8%)
-$21.40 M(-9.6%)
Jun 2015
-
$2.69 M(-44.3%)
-$23.67 M(-7.2%)
Mar 2015
-
$4.83 M(-114.5%)
-$25.50 M(-1.7%)
Dec 2014
-$25.95 M(+470.5%)
-$33.42 M(-1604.8%)
-$25.95 M(-527.9%)
Sep 2014
-
$2.22 M(+157.6%)
$6.06 M(-10.4%)
Jun 2014
-
$862.00 K(-80.4%)
$6.77 M(+326.0%)
Mar 2014
-
$4.39 M(-411.8%)
$1.59 M(-134.9%)
Dec 2013
-$4.55 M(+59.7%)
-$1.41 M(-148.1%)
-$4.55 M(+44.8%)
Sep 2013
-
$2.93 M(-167.8%)
-$3.14 M(-48.2%)
Jun 2013
-
-$4.32 M(+147.0%)
-$6.07 M(+247.0%)
Mar 2013
-
-$1.75 M
-$1.75 M
Dec 2012
-$2.85 M
-
-

FAQ

  • What is Second Sight Medical Products annual cash flow from investing activities?
  • What is the all time high annual CFI for Second Sight Medical Products?
  • What is Second Sight Medical Products annual CFI year-on-year change?
  • What is Second Sight Medical Products quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Second Sight Medical Products?
  • What is Second Sight Medical Products quarterly CFI year-on-year change?
  • What is Second Sight Medical Products TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Second Sight Medical Products?
  • What is Second Sight Medical Products TTM CFI year-on-year change?

What is Second Sight Medical Products annual cash flow from investing activities?

The current annual CFI of EYES is -$14.00 K

What is the all time high annual CFI for Second Sight Medical Products?

Second Sight Medical Products all-time high annual cash flow from investing activities is $17.52 M

What is Second Sight Medical Products annual CFI year-on-year change?

Over the past year, EYES annual cash flow from investing activities has changed by -$82.00 K (-120.59%)

What is Second Sight Medical Products quarterly cash flow from investing activities?

The current quarterly CFI of EYES is $0.00

What is the all time high quarterly CFI for Second Sight Medical Products?

Second Sight Medical Products all-time high quarterly cash flow from investing activities is $6.04 M

What is Second Sight Medical Products quarterly CFI year-on-year change?

Over the past year, EYES quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Second Sight Medical Products TTM cash flow from investing activities?

The current TTM CFI of EYES is -$8.03 M

What is the all time high TTM CFI for Second Sight Medical Products?

Second Sight Medical Products all-time high TTM cash flow from investing activities is $18.53 M

What is Second Sight Medical Products TTM CFI year-on-year change?

Over the past year, EYES TTM cash flow from investing activities has changed by -$8.43 M (-2113.03%)